Physician profile
Ted Bialy
NPI 1801852058
$4,934.01
in general payments reported to CMS, 2019-2025
35 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $998 · 2020: $384 · 2021: $954 · 2022: $638 · 2023: $584 · 2024: $887 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $663.18 | 2019-2024 | Xarelto |
| Pfizer INC. | $526.28 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $480.37 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $372.03 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $348.67 | 2019-2025 | |
| Abbott Laboratories | $212.52 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Merck Sharp & Dohme LLC | $189.83 | 2021-2024 | Verquvo |
| Novo Nordisk INC | $188.83 | 2024-2025 | Wegovy, Ozempic |
| Boston Scientific Corporation | $187.56 | 2019-2023 | Varithena Administration Pack |
| Amarin Pharma, INC. | $162.65 | 2019-2022 | |
| Atricure, INC. | $155.45 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Astrazeneca Pharmaceuticals Lp | $145.57 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.36 | 2019-2025 | Jardiance |
| Abiomed | $137.57 | 2022-2025 | |
| Daiichi Sankyo INC. | $120.45 | 2019-2024 | Injectafer |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Bialy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.